XoWiki mobile view
 

 

Active Studies

Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

Expression of stress markers in MSM living with HIV receiving contingency management for methamphetamine use disorder (a.k.a "EXPRESS+")

Inflammation in Methamphetamine and STIs

A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapvir for HIV Pre-Exposure Prophylaxis (PrEP) in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary people 18 Years of Age or Older who Have Sex with Male Partners and are at Risk of HIV Infection.